Analysis of 4-aminobiphenyl in smoker’s and nonsmoker’s urine by tandem mass spectrometry

References

• Benowitz N, Jocob PI, Ahijevych K, Jarvis M, Hall S, LeHouezec J, Hansson A, Lichtenstein E, Henningfield J, Tsoh J, Hurt R, Velicer W. (2002). Biochemical verification of tobacco use and cessation. Nicotine Tob Res 4:149–159.
   PubMedGoogle Scholar
• Bryant MS, Skipper PL, Tannenbaum SR, Maclure M. (1987). Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res 47:602–608.
   PubMed Web of Science ®Google Scholar
• Bryant MS, Vineis P, Skipper PL, Tannenbaum SR. (1988). Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proc Natl Acad Sci usa 85:9788–9791.
   PubMed Web of Science ®Google Scholar
• Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC. (2001). Gender- and smoking-related bladder cancer risk. j Natl Cancer Inst 93:538–545.
   PubMed Web of Science ®Google Scholar
• Caudill SP, Schleicher RL, Pirkle JL. (2008). Multi-rule quality control for the age-related eye disease study. Stat Med 27:4094–4106.
   PubMed Web of Science ®Google Scholar
• Dallinga JW, Pachen DM, Wijnhoven SW, Breedijk A, van ‘t Veer L, Wigbout G, van Zandwijk N, Maas LM, van Agen E, Kleinjans JC, van Schooten FJ. (1998). The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure. Cancer Epidemiol Biomarkers Prev 7:571–577.
   PubMed Web of Science ®Google Scholar
• DHHS (U.S. Department of Health and Human Services). 2006. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
   Google Scholar
• Fennell TR, MacNeela JP, Morris RW, Watson M, Thompson CL, Bell DA. (2000). Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: effects of glutathione S-transferase T1-null and M1-null genotypes. Cancer Epidemiol Biomarkers Prev 9:705–712.
   PubMed Web of Science ®Google Scholar
• Grimmer G, Dettbarn G, Seidel A, Jacob J. (2000). Detection of carcinogenic aromatic amines in the urine of non-smokers. Sci Total Environ 247:81–90.
   PubMed Web of Science ®Google Scholar
• Hammond SK, Coghlin J, Gann PH, Paul M, Taghizadeh K, Skipper PL, Tannenbaum SR. (1993). Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers. J Natl Cancer Inst 85:474–478.
   PubMedGoogle Scholar
• IARC. (1987). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans.
   Google Scholar
• Jiang X, Yuan JM, Skipper PL, Tannenbaum SR, Yu MC. (2007). Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res 67:7540–7545.
   PubMed Web of Science ®Google Scholar
• Johnson HJ Jr, Cernosek SF Jr, Gutierrez-Cernosek RM, Brown LL. (1980). Development of a radioimmunoassay procedure for 4-acetamidobiphenyl, a metabolite of the chemical carcinogen 4-aminobiphenyl, in urine. J Anal Toxicol 4:86–90.
   PubMed Web of Science ®Google Scholar
• Ketelslegers HB, Godschalk RW, Eskens BJ, Dallinga JW, Gottschalk RW, van Schooten FJ, van Delft JH, Kleinjans JC. (2009). Potential role of cytochrome P450-1B1 in the metabolic activation of 4-aminobiphenyl in humans. Mol Carcinog 48:685–691.
   PubMed Web of Science ®Google Scholar
• Mendes P, Liang Q, Frost-Pineda K, Munjal S, Walk RA, Roethig HJ. (2009). The relationship between smoking machine derived tar yields and biomarkers of exposure in adult cigarette smokers in the US. Regul Toxicol Pharmacol 55:17–27.
   PubMed Web of Science ®Google Scholar
• Richter E, Branner B. (2002). Biomonitoring of exposure to aromatic amines: haemoglobin adducts in humans. J Chromatogr B Analyt Technol Biomed Life Sci 778:49–62.
   PubMed Web of Science ®Google Scholar
• Riedel K, Scherer G, Engl J, Hagedorn HW, Tricker AR. (2006). Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers. J Anal Toxicol 30:187–195.
   PubMed Web of Science ®Google Scholar
• Riffelmann M, Müller G, Schmieding W, Popp W, Norpoth K. (1995). Biomonitoring of urinary aromatic amines and arylamine hemoglobin adducts in exposed workers and nonexposed control persons. Int Arch Occup Environ Health 68:36–43.
   PubMed Web of Science ®Google Scholar
• Sarkar M, Liu J, Koval T, Wang J, Feng S, Serafin R, Jin Y, Xie Y, Newland K, Roethig HJ. (2010). Evaluation of biomarkers of exposure in adult cigarette smokers using Marlboro snus. Nicotine Tob Res 12:105–116.
   PubMed Web of Science ®Google Scholar
• Schnell FC. (1994). Reviews in Environmental Toxicolgoy. Vol. 5. ed. Hodgson E. Toxicology Communications, Inc.: Raleigh, NC:51–160.
   Google Scholar
• Seyler TH, Reyes LR, Bernert JT. (2010). Analysis of 4-aminobiphenyl hemoglobin adducts in smokers and nonsmokers by pseudo capillary on-column gas chromatography-tandem mass spectrometry. J Anal Toxicol 34:304–311.
   PubMed Web of Science ®Google Scholar
• Silverman DT, Hartge P, Morrison AS, Devesa SS. (1992). Epidemiology of bladder cancer. Hematol Oncol Clin North Am 6:1–30.
   PubMed Web of Science ®Google Scholar
• Skipper PL, Tannenbaum SR. (1994). Molecular dosimetry of aromatic amines in human populations. Environ Health Perspect 102 Suppl 6:17–21.
   PubMed Web of Science ®Google Scholar
• Skipper PL, Tannenbaum SR, Ross RK, Yu MC. (2003). Nonsmoking-related arylamine exposure and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 12:503–507.
   PubMed Web of Science ®Google Scholar
• Stillwell WG, Bryant MS, Wishnok JS. (1987). GC/MS analysis of biologically important aromatic amines. Application to human dosimetry. Biomed Environ Mass Spectrom 14:221–227.
   PubMedGoogle Scholar
• Talaska G, Al-Zoughool M. (2003). Aromatic amines and biomarkers of human exposure. J Environ Sci Health c Environ Carcinog Ecotoxicol Rev 21:133–164.
   PubMed Web of Science ®Google Scholar
• Teass AW, DeBord DG, Brown KK, Cheever KL, Stettler LE, Savage RE, Weigel WW, Dankovic D, Ward E. (1993). Biological monitoring for occupational exposures to o-toluidine and aniline. Int Arch Occup Environ Health 65:S115–S118.
   PubMed Web of Science ®Google Scholar
• Vineis P. (1994). Epidemiology of cancer from exposure to arylamines. Environ Health Perspect 102 Suppl 6:7–10.
   PubMed Web of Science ®Google Scholar
• Yu MC, Skipper PL, Taghizadeh K, Tannenbaum SR, Chan KK, Henderson BE, Ross RK. (1994). Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Cancer Inst 86:712–716.
   PubMed Web of Science ®Google Scholar
• Zenser TV, Lakshmi VM, Davis BB. (1999). Human and Escherichia coli beta-glucuronidase hydrolysis of glucuronide conjugates of benzidine and 4-aminobiphenyl, and their hydroxy metabolites. Drug Metab Dispos 27:1064–1067.
   PubMed Web of Science ®Google Scholar